Clinical Definition
TECSA is characterized by:
- Therapy-Induced Events: Central apneas that emerge during treatment
- Previous OSA: Patient had predominantly obstructive events
- CPAP-Related: Central events appear with positive pressure therapy
- Treatment Resistance: Standard CPAP may be ineffective
- Alternative Therapy Needs: Often requires ASV or specialized treatment
TECSA can occur immediately during titration or develop after periods of successful CPAP therapy.
Etymology & History
Reference Values & Interpretation
Normal Values
Normal PAP therapy should not cause significant central apneas in patients with pure obstructive sleep apnea.
Abnormal Values
TECSA is present when central AHI ≥5 emerges during PAP therapy in patients with predominantly obstructive sleep apnea on baseline testing.
How It's Measured
TECSA is diagnosed through sleep studies or PAP device data showing the emergence of central apneas during therapy.
Role in Diagnosis
TECSA diagnosis requires documentation of central apneas during therapy in patients with previously obstructive sleep apnea.
Role in Treatment
TECSA often requires alternative treatments such as ASV, BiPAP with backup rate, or adjustment of therapy approach to address the central component.
Associated Conditions
complex-sleep-apnea|central-apnea|asv|cpap-therapy
Clinical Guidelines
[{"guideline_title":"AASM Clinical Practice Guideline for Treatment-Emergent Central Sleep Apnea","guideline_link":"/clinical/guidelines/aasm-tecsa/"}]
Latest Research & Updates
Recent research has investigated the mechanisms of TECSA and optimal treatment approaches, with some cases resolving spontaneously over time while others require long-term specialized therapy.